An insight to biomaterials
On June 15, 2017, the Copenhagen Bioscience Lecture will give you an insight in biomaterials with leading experts Marcel Karperien and Dirk Grijpma from the University of Twente in The Netherlands.
The Novo Nordisk Foundation Cluster Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. Every 4 weeks, on a Thursday evening, you are invited for lectures on themes with a general interest for the Novo Nordisk Foundation Research Centers. Often there will be a cross-disciplinary focus.
PROGRAMME
15:45 | Welcome and registration (coffee/tea, fruit, water available) |
16:00 | Talk by Professor Marcel Karperien, Developmental BioEngineering, University of Twente, The Netherlands |
16:45 | Talk by Professor Dirk Grijpma, Department of Biomaterials Science and Technology, University of Twente, The Netherlands |
17:30 | Networking with a drink and a snack |
18:30 | Thank you for a splendid end of day! |
ABOUT PROFESSOR MARCEL KARPERIEN
Marcel Karperien studied biology at Utrecht University. After graduation in 1991 he worked as a PhD-student at the Netherlands Institute for Developmental Biology and Stem Cell Research. He continued his career at the Leiden University Medical Center working on regulation of longitudinal bone growth and metabolic bone disorders. In 2007 he moved to the MIRA Institute for Biomedical Technology and Technical Medicine where he established the Department of Developmental BioEngineering.
He is interested in developing new solutions for treating cartilage related disorders. His work is technology inspired and is characterized by a multidisciplinary approach. In his work in depth knowledge of the molecular and cellular biology of cartilage is combined with state of the art chemical- and nano-technology. Specific research topics are the development of injectable hydrogel platforms for recreating dedicated cell niches for guiding stem cell differentiation and tissue reconstruction. This platform is developed for application in regenerative medicine focusing on repair of articular cartilage and beta cell differentiation for treating type I diabetes. More recently this platform is developed for application in organ-on-chip models. Marcel Karperien has received awards from the American Society for Bone and Mineral Research (Young investigator award, travel grant awards), Dutch Society for Endocrinology (NVE), the European Calcified Tissue Society and the MIRA Institute for Biomedical Technology and Technical Medicine for his work. His work is supported by an unrestricted research grant from the Dutch Arthritis Foundation.
Prof. Dr. D.W. Grijpma is appointed at the University of Twente in the Department of Biomaterials Science and Technology, and also affiliated with the Department of Biomedical Engineering, University Medical Center Groningen of the University of Groningen.
His research is aimed at the development of resorbable polymeric materials for application in tissue engineering and clinical use as medical implants such as resorbable hydrogels, drug releasing nano- and micro particles and scaffolds for tissue engineering. His expertise lies in the development of functional polymeric materials, their structure-properties relationships and their processing into implantable structures. The preparation of functionalized macromers by ringopening polymerization of lactones and cyclic carbonates and subsequent functionalization to yield reactive end groups, allows the preparation of resorbable networks through rapid prototyping techniques such as stereolithography. Implants with a well defined geometry and biological functionality can readily be prepared in this manner.
TIME AND LOCATION
15 June 2017, 16:00-18:30
Novo Nordisk Foundation
Tuborg Havnevej 19
DK-2900 Hellerup
REGISTRATION
Registration is free of charge, but mandatory via the event's program website on Eventbrite. Please also remember to unregister in case of cancellation.
FURTHER INFORMATION
For further information about the event please contact Sophie Labrosse at sfeb@novo.dk or go to the Novo Nordisk Foundation website